Literature DB >> 19843885

Appearance of peripheral blood plasma cells and memory B cells in a primary and secondary immune response in humans.

Geraldine Blanchard-Rohner1, Anoop S Pulickal, Cornelia M Jol-van der Zijde, Matthew D Snape, Andrew J Pollard.   

Abstract

In humans, the kinetics of the appearance of memory B cells and plasma cells during primary immunization are not well defined. In this study, we assessed the primary B-cell response of rabies-antigen naive volunteers during a 3-dose course of rabies vaccine compared with the B-cell response to a booster dose of rabies vaccine given to previously immunized volunteers. After a single dose of vaccine, in the naive group plasma and memory B cells appeared later (peak at day 10) than in the primed group (peak at day 7) and were at lower frequency. The most rapid responses (day 4) were detected after a third immunization in the naive group. This is the first study to document the detailed kinetics of the plasma cell and memory B-cell responses to immunization in adult humans and to demonstrate differences in the responses that relate to the preexisting immune status of the persons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843885      PMCID: PMC2788974          DOI: 10.1182/blood-2009-03-211052

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

1.  Contrasting the in situ behavior of a memory B cell clone during primary and secondary immune responses.

Authors:  K A Vora; K Tumas-Brundage; T Manser
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

2.  Treatment with rituximab affects both the cellular and the humoral arm of the immune system in patients with SLE.

Authors:  Therese Vallerskog; Iva Gunnarsson; Mona Widhe; Anke Risselada; Lars Klareskog; Ronald van Vollenhoven; Vivianne Malmström; Christina Trollmo
Journal:  Clin Immunol       Date:  2006-10-13       Impact factor: 3.969

3.  The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response.

Authors:  K G Smith; A Light; G J Nossal; D M Tarlinton
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

4.  Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response.

Authors:  T Nieminen; H Käyhty; A Virolainen; J Eskola
Journal:  Vaccine       Date:  1998 Jan-Feb       Impact factor: 3.641

5.  The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM conjugate vaccine.

Authors:  Elizabeth A Clutterbuck; Penny Salt; Sarah Oh; Arnaud Marchant; Peter Beverley; Andrew John Pollard
Journal:  Immunology       Date:  2006-11       Impact factor: 7.397

6.  The phenotype and fate of the antibody-forming cells of the splenic foci.

Authors:  K G Smith; T D Hewitson; G J Nossal; D M Tarlinton
Journal:  Eur J Immunol       Date:  1996-02       Impact factor: 5.532

7.  CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells.

Authors:  Dominic F Kelly; Mathew D Snape; Elizabeth A Clutterbuck; Elizabeth A Cutterbuck; Sarah Green; Claire Snowden; Linda Diggle; Ly-mee Yu; Astrid Borkowski; E Richard Moxon; Andrew J Pollard
Journal:  Blood       Date:  2006-05-04       Impact factor: 22.113

8.  Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization.

Authors:  Elizabeth J Blink; Amanda Light; Axel Kallies; Stephen L Nutt; Philip D Hodgkin; David M Tarlinton
Journal:  J Exp Med       Date:  2005-02-14       Impact factor: 14.307

9.  Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation.

Authors:  Didrik Paus; Tri Giang Phan; Tyani D Chan; Sandra Gardam; Antony Basten; Robert Brink
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

10.  Identification of functional human splenic memory B cells by expression of CD148 and CD27.

Authors:  S G Tangye; Y J Liu; G Aversa; J H Phillips; J E de Vries
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

View more
  50 in total

Review 1.  Experimental rabies vaccines for humans.

Authors:  James P McGettigan
Journal:  Expert Rev Vaccines       Date:  2010-10       Impact factor: 5.217

2.  Mechanistic insights into the impairment of memory B cells and antibody production in the elderly.

Authors:  Judith H Aberle; Karin Stiasny; Michael Kundi; Franz X Heinz
Journal:  Age (Dordr)       Date:  2012-01-27

3.  Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.

Authors:  Shannon L Haley; Evgeni P Tzvetkov; Samantha Meuwissen; Joseph R Plummer; James P McGettigan
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

4.  Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults.

Authors:  F Eun-Hyung Lee; Ann R Falsey; Jessica L Halliley; Iñaki Sanz; Edward E Walsh
Journal:  J Infect Dis       Date:  2010-10-27       Impact factor: 5.226

5.  Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot.

Authors:  Johannes Trück; Ruth Mitchell; Amber J Thompson; Begonia Morales-Aza; Elizabeth A Clutterbuck; Dominic F Kelly; Adam Finn; Andrew J Pollard
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

6.  Polysaccharide-specific B cell responses to vaccination in humans.

Authors:  Ruth Mitchell; Dominic F Kelly; Andrew J Pollard; Johannes Trück
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

7.  Pertussis-specific memory B-cell and humoral IgG responses in adolescents after a fifth consecutive dose of acellular pertussis vaccine.

Authors:  Maja Jahnmatz; Margaretha Ljungman; Eva Netterlid; Maria C Jenmalm; Lennart Nilsson; Rigmor Thorstensson
Journal:  Clin Vaccine Immunol       Date:  2014-07-09

8.  Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model.

Authors:  Thorsten Demberg; Venkatramanan Mohanram; David Venzon; Marjorie Robert-Guroff
Journal:  Clin Immunol       Date:  2014-05-09       Impact factor: 3.969

9.  Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques.

Authors:  Caroline Petitdemange; Sudhir Pai Kasturi; Pamela A Kozlowski; Rafiq Nabi; Clare F Quarnstrom; Pradeep Babu Jagadeesh Reddy; Cynthia A Derdeyn; Lori M Spicer; Parin Patel; Traci Legere; Yevgeniy O Kovalenkov; Celia C Labranche; François Villinger; Mark Tomai; John Vasilakos; Barton Haynes; C Yong Kang; James S Gibbs; Jonathan W Yewdell; Dan Barouch; Jens Wrammert; David Montefiori; Eric Hunter; Rama R Amara; David Masopust; Bali Pulendran
Journal:  JCI Insight       Date:  2019-02-21

10.  Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdom.

Authors:  Maheshi N Ramasamy; Elizabeth A Clutterbuck; Kathryn Haworth; Jaclyn Bowman; Omar Omar; Amber J Thompson; Geraldine Blanchard-Rohner; Ly-Mee Yu; Matthew D Snape; Andrew J Pollard
Journal:  Clin Vaccine Immunol       Date:  2014-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.